11301377

Source:http://linkedlifedata.com/resource/pubmed/id/11301377

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022065, umls-concept:C0546837
pubmed:issue	2
pubmed:dateCreated	2001-4-13
pubmed:abstractText	Esophageal cancer is among the 10 most frequent cancers in the world. Iran is one of the known areas with a high incidence of esophageal cancer. Most of the patients in Iran have been reported from the north and northeast regions of the country. In one survey by the Iran Cancer Institute, 9% of all cancers and 27% of gastrointestinal cancers were esophageal carcinoma. The male to female ratio was 1.7/1. The distal portion of the esophagus is involved more often than other parts. Consumption of wheat flour, exposure to residues from opium pipes, drinking hot tea, and chewing nass (a mixture of tobacco, lime, ash, and other ingredients) are the suspect etiologic agents for esophageal cancer in Iran. Dysphagia, weight loss, anorexia, abdominal pain, and odynophagia are the common symptoms and signs of Iranian patients with esophageal cancer. For clinical staging, chest computed tomographic scanning is performed. Adenocarcinoma of the esophagus is not as common in Iran as in western countries. Public education, nutritional support, and eradication of opium addiction may decrease the morbidity and mortality that result from esophageal cancer. Surgery has traditionally been the mainstay of esophageal cancer treatment in Iran. Radiotherapy is mainly used postoperatively. The usual combination chemotherapy regimen is cisplatin plus flurouracil (5-Fu). Semin Oncol 28:153-157.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0420432
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0093-7754
pubmed:author	pubmed-author:GhavamzadehAA, pubmed-author:IravaniMM, pubmed-author:JahaniMM, pubmed-author:MoussaviAA, pubmed-author:RastegarpanahMM
pubmed:copyrightInfo	Copyright 2001 by W.B. Saunders Company.
pubmed:issnType	Print
pubmed:volume	28
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	153-7
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:11301377-Developing Countries, pubmed-meshheading:11301377-Esophageal Neoplasms, pubmed-meshheading:11301377-Female, pubmed-meshheading:11301377-Humans, pubmed-meshheading:11301377-Iran, pubmed-meshheading:11301377-Male, pubmed-meshheading:11301377-Risk Factors
pubmed:year	2001
pubmed:articleTitle	Esophageal cancer in Iran.
pubmed:affiliation	Department of Oncology, Hematology and Bone Marrow Transplant, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
pubmed:publicationType	Journal Article, Review